Significance of serum bactericidal activity in gram-negative bacillary bacteremia in patients with and without granulocytopenia.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  American Journal of Medicine

• Publication date

  1984-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9343(84)90662-4PMID 6702874
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synergistic combinations of antibiotics in gram-negative bacillary infections.

  1982cited by this paper
• Association between serum inhibitory and bactericidal concentrations and therapeutic outcome in bacterial endocarditis.

  1982cited by this paper
• Analysis of Serum Bactericidal Activity In Endocarditis, Osteomyelitis, and Other Bacterial Infections

  1981cited by this paper
• Use of the serum bactericidal titer to assess the adequacy of oral antibiotic therapy in the treatment of acute hematogenous osteomyelitis.

  1979cited by this paper
• Principles and practice of infectious diseases. Vols 1 and 2.

  1979cited by this paper
• Endotracheally administered antibiotics for gram-negative bronchopneumonia.

  1979cited by this paper
• Oral antibiotic therapy for skeletal infections of children. I. Antibiotic concentrations in suppurative synovial fluid.

  1978cited by this paper
• Oral antibiotic therapy for skeletal infections of children. II. Therapy of osteomyelitis and suppurative arthritis.

  1978cited by this paper
• Significance of antimicrobial synergism for the outcome of gram negative sepsis.

  1977cited by this paper
• A pharmacologic evaluation of penicillin in children with purulent meningitis.

  1977cited by this paper
• Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility tests.

  1977cited by this paper
• Gram-negative sepsis.

  1976cited by this paper
• Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections.

  1974cited by this paper
• Clinical Significance of In Vitro Synergism Between Antibiotics in Gram-Negative Infections

  1972cited by this paper
• Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia.

  1971cited by this paper
• Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.

  1966cited by this paper
• A method of determining the effective therapeutic level in the treatment of subacute bacterial endocarditis with penicillin; a preliminary report.

  1947cited by this paper

• Is it possible to shorten serum bactericidal testing?

  2019cites this paper
• Optimizing Antimicrobial Therapy of Sepsis and Septic Shock: Focus on Antibiotic Combination Therapy

  2015cites this paper
• Empiric Antimicrobial Therapy in Severe Sepsis and Septic Shock: Optimizing Pathogen Clearance

  2015cites this paper
• the Presence of Lung Surfactant Expanded-Spectrum Lipopeptide Active in Antimicrobial Properties of MX-2401, an

  2014cites this paper
• An alternate pathophysiologic paradigm of sepsis and septic shock

  2013cites this paper
• Flash microbiocide: A Rapid and Economic Method for Determination of MBC and MFC

  2013cites this paper
• In Vitro Antibacterial and Time-Kill Assessment of Crude Methanolic Stem Bark Extract of Acacia mearnsii De Wild against Bacteria in Shigellosis

  2012cites this paper
• Current concepts in laboratory testing to guide antimicrobial therapy.

  2012cites this paper
• Antimicrobial Properties of MX-2401, an Expanded-Spectrum Lipopeptide Active in the Presence of Lung Surfactant

  2011cites this paper
• Infections Caused by Aerobic and Anaerobic Gram-Negative Bacilli

  2011cites this paper
• Phenotypic Methods for Detecting Antibacterial Resistance

  2011cites this paper
• Microbiological equivalence of serum bacteriostatic and bactericidal activities of the sera from healthy volunteers receiving original meropenem (Meronem) and generic meropenem (Mero).

  2010cites this paper
• Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia.

  2008cites this paper
• Serum Bactericidal Testing

  2007cites this paper
• Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin.

  2006cites this paper
• Challenges in the treatment of infections caused by gram-positive and gram-negative bacteria in patients with cancer and neutropenia.

  2005cites this paper
• Systemic antimicrobial therapy of nosocomial pneumonia: Monotherapy versus combination therapy

  2005cites this paper
• Cephalosporins — Cefotaxime 10 years later, a major drug with continued use

  2005cites this paper
• Determination of Fungicidal Activities against Yeasts and Molds: Lessons Learned from Bactericidal Testing and the Need for Standardization

  2004cites this paper
• Gram-negative bacteremia

  2004cites this paper
• The importance of bactericidal drugs: future directions in infectious disease.

  2004cites this paper
• Dead Bugs Don’t Mutate: Susceptibility Issues in the Emergence of Bacterial Resistance

  2003cites this paper
• Effect of serum from different patient populations on the serum bactericidal test.

  2001cites this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Isepamicin

  2000cites this paper
• Bacteraemia among patients attending a cancer hospital in Lahore, Pakistan.

  2000cites this paper
• Targeting gentamicin concentrations in babies: the younger the baby, the larger the loading dose and the longer the dose interval

  2000cites this paper
• Prevention of infection in multiple trauma patients by high‐dose intravenous immunoglobulins

  2000cites this paper
• Levofloxacin Pharmacokinetics and Serum Bactericidal Activities against Five Enterobacterial Species

  2000cites this paper
• An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients. German Multicentre Study Group.

  1999cites this paper
• Isepamicin in intensive care unit patients with nosocomial pneumonia: population pharmacokinetic-pharmacodynamic study.

  1999cites this paper
• Letters to the Editor

  1999cites this paper
• Letters to the Editor

  1999cites this paper
• Population Pharmacokinetic Study of Amikacin Administered Once or Twice Daily to Febrile, Severely Neutropenic Adults

  1998cites this paper
• Once-Daily High-Dose Netilmicin

  1998cites this paper
• The bactericidal activity of gatifloxacin in plasma and urine.

  1998cites this paper
• Staphylococcus epidermidis: emerging resistance and need for alternative agents.

  1998cites this paper
• Pharmacoeconomics of antimicrobial usage in the secondary care sector

  1998cites this paper
• A review of in-vitro antibacterial activity of quinupristin/dalfopristin against methicillin-susceptible and -resistant Staphylococcus aureus.

  1997cites this paper
• External quality assessment of the serum bactericidal test: results of a methodology/interpretation questionnaire.

  1997cites this paper
• The importance of in-vitro susceptibility testing in the management of compromised hosts.

  1997cites this paper
• [Serum bactericidal rate. Methodological proposal to predict the efficacy of antimicrobial therapy].

  1996cites this paper
• Relevance of the Alexander Project: pharmacodynamic considerations.

  1996cites this paper
• Pharmacokinetics of sparfloxacin and serum bactericidal activity against pneumococci

  1996cites this paper
• Empiric monotherapy in neutropenia: a realistic goal?

  1995cites this paper
• Nucleoside-nucleotide mixture increases peripheral neutrophils in cyclophosphamide-induced neutropenic mice.

  1995cites this paper
• Comparison of fosfomycin and teicoplanin in serum bactericidal activity against staphylococci.

  1995cites this paper
• In vitro testing of antimicrobial agents.

  1995cites this paper
• A mixture of nucleosides and nucleotides increases bone marrow cell and peripheral neutrophil number in mice infected with methicillin-resistant Staphylococcus aureus.

  1995cites this paper
• The comparative inhibitory and bactericidal activities of meropenem and imipenem against Acinetobacter spp. and Enterobacteriaceae resistant to second generation cephalosporins.

  1995cites this paper
• Comparative serum bactericidal activity against Pseudomonas aeruginosa of six antipseudomonal agents.

  1995cites this paper
• Zinc deficiency causes oxidative damage to proteins, lipids and DNA in rat testes.

  1995cites this paper
• Infections in cancer patients: some controversial issues

  1994cites this paper
• Comparative crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin and ofloxacin.

  1994cites this paper
• Comparative serum bactericidal activities of three doses of ciprofloxacin administered intravenously

  1994cites this paper
• 抗生 (菌) 物質のin vitro抗菌力の臨床利用への問題点

  1993cites this paper
• Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.

  1993cites this paper
• Empirical antibiotic therapy in neutropenic cancer patients.

  1993cites this paper
• Double β-lactam regimen compared to an aminoglycoside/β-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients

  1993cites this paper
• Ceftriaxone versus latamoxef in febrile neutropenic patients: empirical monotherapy in patients with solid tumours.

  1993cites this paper
• Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidime

  1993cites this paper
• Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid

  1993cites this paper
• [Evaluation of the serum bactericidal test].

  1993cites this paper
• Serum inhibitory and bactericidal activity against methicillin-resistant Staphylococcus aureus in volunteers receiving novobiocin and rifampin alone and in combination.

  1993cites this paper
• Fever and neutropenia during intensive chemotherapy.

  1993cites this paper
• Bactericidal testing.

  1993cites this paper
• The serum bactericidal test revisited

  1993cites this paper
• Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance

  1992cites this paper
• Immunocompromised Host Infections

  1992cites this paper
• Pseudomonas aeruginosa infection in cancer patients.

  1992cites this paper
• Pseudomonas aeruginosa Infection in Cancer Patients: Infectious complications of cancer

  1992cites this paper
• Augmentated anti-Pseudomonas Activity in Cyclophosphamide-Induced

  1992cites this paper
• Bactericidal titers of loracarbef (LY 163892) in serum and killing rates in volunteers receiving 400 versus 200 milligrams

  1992cites this paper
• Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study

  1992cites this paper
• Tests forBactericidal Effects ofAntimicrobial Agents: Technical Performance andClinical Relevance

  1992cites this paper
• Bactericidal titers of loracarbef (LY 163892) in serum and killing rates in volunteers receiving 400 versus 200 milligrams.

  1992cites this paper
• Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone.

  1991cites this paper
• Ceftazidime monotherapy for empiric treatment of febrile neutropenic patients: a meta-analysis.

  1991cites this paper
• Susceptibility testing of Listeria monocytogenes. A reassessment of bactericidal activity as a predictor for clinical outcome.

  1991cites this paper
• Empirical antimicrobial therapy with a single daily dose of ceftriaxone plus amikacin in febrile granulocytopenic patients: a pilot study.

  1991cites this paper
• Cephalosporins — Cefotaxime 10 years later, a major drug with continued use

  1991cites this paper
• Pharmacodynamic parameters and toxicity of netilmicin (6 milligrams/kilogram/day) given once daily or in three divided doses to cancer patients with urinary tract infection

  1991cites this paper
• Mechanism of Protective Effect of Recombinant Human Granulocyte Colony‐Stimulating Factor (rG‐CSF) on Pseudomonas Infection

  1991cites this paper
• Clinical efficacy and in vitro activity of the ciprofloxacin-azlocillin combination (ratio 1:10) against gram-negative bacteria from non-neutropenic haematologic patients.

  1991cites this paper
• Pharmacokinetic evaluation of single daily dose amikacin.

  1991cites this paper
• Gentamicin pharmacokinetics in patients with malignancies

  1991cites this paper
• Serum Bactericidal Titres After Cefoperazone With and Without Sulbactam

  1990cites this paper
• Gentamicin in Neonates: The Need for Loading Doses

  1990cites this paper
• Pharmacokinetics and serum bactericidal activities of quinolones in combination with clindamycin, metronidazole, and ornidazole

  1990cites this paper
• Therapy: the clinician's view.

  1990cites this paper
• Pharmacodynamic Properties of Antibiotics: Application to Drug Monitoring and Dosage Regimen Design

  1990cites this paper
• Ceftriaxone vs. azlocillin and netilmicin in the treatment of febrile neutropenic children.

  1990cites this paper
• Study of the influence of protein binding on serum bactericidal titres and killing rates in volunteers receiving ceftazidime, cefotaxime and ceftriaxone.

  1990cites this paper
• Pharmacodynamics of Antibiotics-Consequences for Dosing: Proceedings of a Symposium Held in Stockholm, June 7–9, 1990

  1990cites this paper
• Assessing cidal activity of antimicrobial agents: Problems and pitfalls

  1990cites this paper
• Serum Bactericidal Titres after Cefoperazone and Ceftazidime With and Without Amikacin

  1990cites this paper
• Crossover assessment of serum bactericidal activity and pharmacokinetics of five broad-spectrum cephalosporins in the elderly

  1990cites this paper
• Empiric treatment of infection during granulocytopenia.

  1990cites this paper
• Protective Effect of Recombinant Human Granulocyte Colony‐Stimulating Factor (rG‐CSF) against Various Microbial Infections in Neutropenic Mice

  1990cites this paper
• Pharmacodynamic properties of antibiotics: application to drug monitoring and dosage regimen design.

  1990cites this paper
• [Antibiotherapy in the patient with granulocytopenic cancer].

  1990cites this paper